As of October 27, 2026, GeoVax Labs, Inc. is a publicly traded company (Nasdaq: GOVX). The largest insider holding is David A. Dodd, the chief executive and president, with 36,661 shares (0.50% of shares outstanding), per Form 4 of April 1, 2025. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G, June 9, 2026).
About to sign with, pay or invest in GeoVax Labs, Inc.? See the free Snapshot first.
Free to see. No signup.
Is GeoVax Labs, Inc. a real, registered company?
- GeoVax Labs, Inc. files with the SEC under CIK 832489 (its SEC filings).
- Its shares are listed under the ticker GOVX on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Smyrna, Georgia, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under GEOVAX LABS, INC. in our court records and SEC 8-K records (as of 2026-10-27).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Jane Street (filed 2026-06-09).
Who are GeoVax Labs, Inc.'s owners and officers?
GeoVax Labs, Inc.: incorporated in Delaware; business address in Smyrna, Georgia; industry Pharmaceutical Preparations (S-1, 2026-09-17).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Armistice Capital, LLC | 4.99% |
| Schedule 13G/A, 2026-08-13 | Mitchell P. Kopin | 4.99% |
| Schedule 13G/A, 2026-08-13 | Ayrton Capital LLC | 1.59% |
| Schedule 13G/A, 2026-08-10 | Jane Street Group, LLC | 4.3% |
| Schedule 13G, 2026-06-09 | Jane Street Group, LLC | 5.6% |
| Schedule 13G/A, 2026-05-15 | Armistice Capital, LLC | 9.99% |
| Schedule 13G/A, 2026-05-13 | Mitchell P. Kopin | 9.99% |
| Schedule 13G/A, 2026-02-17 | Armistice Capital, LLC | 8.26% |
| Schedule 13G/A, 2026-02-17 | L1 Capital Global Opportunities Master Fund, LTD. | 1.79% |
| Schedule 13G/A, 2026-02-13 | Mitchell P. Kopin | 9.99% |
| Schedule 13G, 2026-02-11 | Ayrton Capital LLC | 9.99% |
| Schedule 13G/A, 2025-11-07 | Mitchell P. Kopin | 9.99% |
Want the whole picture on GeoVax Labs, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on GeoVax Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on GeoVax Labs, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
23 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own GeoVax Labs, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and president: 36,661 shares (0.50% of shares outstanding) (Form 4, 2025-04-01).
- , a director: 21,402 shares (0.29% of shares outstanding) (Form 4, 2025-10-20).
- , the chief financial officer: 14,013 shares (0.19% of shares outstanding) (Form 4, 2025-03-31).
- , the vice president and business development: 6,191 shares (0.08% of shares outstanding) (Form 4, 2025-04-10).
- , the chief medical officer: 3,494 shares (0.05% of shares outstanding) (Form 4, 2025-08-08).
Shares outstanding: 7,369,243 as of 2026-07-27, from the company's latest SEC cover page.
How much has GeoVax Labs, Inc. raised?
Latest IPO step: GeoVax Labs, Inc. filed to go public (S-1, 2026-09-17).
IPO filings: S-1, 2026-09-17, S-1, 2026-05-26, S-1, 2026-04-16, S-1, 2026-04-16, 424B4, 2025-12-22; ticker GOVX on Nasdaq Capital Market.
Keep reading
More on GeoVax Labs, Inc. and the records around it.
Companies that share a holder
- Ayrton Capital LLC also filed stake reports on 31 other companies: Bluejay Diagnostics, Inc. (Aug 2026), BTC Digital Ltd. (Aug 2026), CHINA NATURAL RESOURCES INC (Aug 2026)
- L1 Capital Global Opportunities Master Fund, Ltd. also filed stake reports on 41 other companies: INLIF Ltd (Oct 2026), DarkIris Inc. (Oct 2026), Baird Medical Investment Holdings Ltd (Oct 2026)
- Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/geovax-labs